A citation-based method for searching scientific literature

Ana Cristina Vargas, Jorge S Reis-Filho, Sunil R Lakhani. J Mammary Gland Biol Neoplasia 2011
Times Cited: 24







List of co-cited articles
161 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, Susan M Domchek, Diana Eccles, Heli Nevanlinna, Susan J Ramus, Amanda Spurdle, Mark Robson, Mark Sherman,[...]. Cancer Epidemiol Biomarkers Prev 2012
328
25

Pathology of hereditary breast cancer.
Petra van der Groep, Elsken van der Wall, Paul J van Diest. Cell Oncol (Dordr) 2011
83
20

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
20

Genome-wide association study identifies novel breast cancer susceptibility loci.
Douglas F Easton, Karen A Pooley, Alison M Dunning, Paul D P Pharoah, Deborah Thompson, Dennis G Ballinger, Jeffery P Struewing, Jonathan Morrison, Helen Field, Robert Luben,[...]. Nature 2007
20

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
Nazneen Rahman, Sheila Seal, Deborah Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Katarina Spanova, Rita Barfoot, Tasnim Chagtai,[...]. Nat Genet 2007
657
20

Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data.
P van der Groep, A Bouter, R van der Zanden, I Siccama, F H Menko, J J P Gille, C van Kalken, E van der Wall, R H M Verheijen, P J van Diest. J Clin Pathol 2006
58
20

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.
José Palacios, Emiliano Honrado, Ana Osorio, Alicia Cazorla, David Sarrió, Alicia Barroso, Sandra Rodríguez, Juan C Cigudosa, Orland Diez, Carmen Alonso,[...]. Clin Cancer Res 2003
133
20

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
20

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
Alfons Meindl, Heide Hellebrand, Constanze Wiek, Verena Erven, Barbara Wappenschmidt, Dieter Niederacher, Marcel Freund, Peter Lichtner, Linda Hartmann, Heiner Schaal,[...]. Nat Genet 2010
459
20

Pathology of hereditary breast cancer.
Leonard Da Silva, Sunil R Lakhani. Mod Pathol 2010
54
16

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.
Sunil R Lakhani, Marc J Van De Vijver, Jocelyne Jacquemier, Thomas J Anderson, Peter P Osin, Lesley McGuffog, Douglas F Easton. J Clin Oncol 2002
586
16

Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors.
Ricardo Fernández-Ramires, Gonzalo Gómez, Iván Muñoz-Repeto, Loris de Cecco, Gemma Llort, Alicia Cazorla, Ignacio Blanco, Manuela Gariboldi, Marco Alessandro Pierotti, Javier Benítez,[...]. Int J Cancer 2011
11
36

Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Rogier A Oldenburg, Karin Kroeze-Jansema, Hanne Meijers-Heijboer, Cristi J van Asperen, Nicoline Hoogerbrugge, Inge van Leeuwen, Hans F A Vasen, Anne-Marie Cleton-Jansen, Jaennelle Kraan, Jeanine J Houwing-Duistermaat,[...]. Clin Cancer Res 2006
29
16

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
16

Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
16


Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
L Melchor, E Honrado, M J García, S Alvarez, J Palacios, A Osorio, K L Nathanson, J Benítez. Oncogene 2008
63
16

The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.
Göran Jönsson, Johan Staaf, Johan Vallon-Christersson, Markus Ringnér, Sofia K Gruvberger-Saal, Lao H Saal, Karolina Holm, Cecilia Hegardt, Adalgeir Arason, Rainer Fagerholm,[...]. Cancer Res 2012
37
16

The molecular portraits of breast tumors are conserved across microarray platforms.
Zhiyuan Hu, Cheng Fan, Daniel S Oh, J S Marron, Xiaping He, Bahjat F Qaqish, Chad Livasy, Lisa A Carey, Evangeline Reynolds, Lynn Dressler,[...]. BMC Genomics 2006
960
16

Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.
Francisco Javier Gracia-Aznarez, Victoria Fernandez, Guillermo Pita, Paolo Peterlongo, Orlando Dominguez, Miguel de la Hoya, Mercedes Duran, Ana Osorio, Leticia Moreno, Anna Gonzalez-Neira,[...]. PLoS One 2013
70
16

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
Sheila Seal, Deborah Thompson, Anthony Renwick, Anna Elliott, Patrick Kelly, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Munaza Ahmed, Katarina Spanova,[...]. Nat Genet 2006
493
16

The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.
S R Lakhani, B A Gusterson, J Jacquemier, J P Sloane, T J Anderson, M J van de Vijver, D Venter, A Freeman, A Antoniou, L McGuffog,[...]. Clin Cancer Res 2000
163
16


Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.
S R Lakhani, J Jacquemier, J P Sloane, B A Gusterson, T J Anderson, M J van de Vijver, L M Farid, D Venter, A Antoniou, A Storfer-Isser,[...]. J Natl Cancer Inst 1998
507
16

Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases.
Izabela Brozek, Magdalena Ratajska, Magdalena Piatkowska, Anna Kluska, Aneta Balabas, Michalina Dabrowska, Dorota Nowakowska, Anna Niwinska, Jadwiga Rachtan, Jan Steffen,[...]. Fam Cancer 2012
16
25

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
630
16

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
16

Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc, Tammi Vickery, Sherri Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu,[...]. J Clin Oncol 2009
16

Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes.
Jord H A Nagel, Justine K Peeters, Marcel Smid, Anieta M Sieuwerts, Marijke Wasielewski, Vanja de Weerd, Anita M A C Trapman-Jansen, Ans van den Ouweland, Hennie Brüggenwirth, Wilfred F J van I Jcken,[...]. Breast Cancer Res Treat 2012
29
16

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays.
Anita L Bane, Jeanne C Beck, Ira Bleiweiss, Saundra S Buys, Edison Catalano, Mary B Daly, Graham Giles, Andy K Godwin, Hanina Hibshoosh, John L Hopper,[...]. Am J Surg Pathol 2007
95
12

Cancer statistics, 2010.
Ahmedin Jemal, Rebecca Siegel, Jiaquan Xu, Elizabeth Ward. CA Cancer J Clin 2010
12

A common coding variant in CASP8 is associated with breast cancer risk.
Angela Cox, Alison M Dunning, Montserrat Garcia-Closas, Sabapathy Balasubramanian, Malcolm W R Reed, Karen A Pooley, Serena Scollen, Caroline Baynes, Bruce A J Ponder, Stephen Chanock,[...]. Nat Genet 2007
416
12

Subtypes of familial breast tumours revealed by expression and copy number profiling.
Nic Waddell, Jeremy Arnold, Sibylle Cocciardi, Leonard da Silva, Anna Marsh, Joan Riley, Cameron N Johnstone, Mohammed Orloff, Guillaume Assie, Charis Eng,[...]. Breast Cancer Res Treat 2010
76
12

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.
Sunil R Lakhani, Jorge S Reis-Filho, Laura Fulford, Frederique Penault-Llorca, Marc van der Vijver, Suzanne Parry, Timothy Bishop, Javier Benitez, Carmen Rivas, Yves-Jean Bignon,[...]. Clin Cancer Res 2005
445
12

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Hanne Meijers-Heijboer, Ans van den Ouweland, Jan Klijn, Marijke Wasielewski, Anja de Snoo, Rogier Oldenburg, Antoinette Hollestelle, Mark Houben, Ellen Crepin, Monique van Veghel-Plandsoen,[...]. Nat Genet 2002
776
12

Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci.
Juan Manuel Rosa-Rosa, Guillermo Pita, Miguel Urioste, Gemma Llort, Joan Brunet, Conxi Lázaro, Ignacio Blanco, Teresa Ramón y Cajal, Orland Díez, Miguel de la Hoya,[...]. Am J Hum Genet 2009
25
12

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
Göran Jönsson, Johan Staaf, Johan Vallon-Christersson, Markus Ringnér, Karolina Holm, Cecilia Hegardt, Haukur Gunnarsson, Rainer Fagerholm, Carina Strand, Bjarni A Agnarsson,[...]. Breast Cancer Res 2010
127
12

Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors.
Emiliano Honrado, Ana Osorio, José Palacios, Roger L Milne, Lydia Sánchez, Orland Díez, Alicia Cazorla, Kirsi Syrjakoski, David Huntsman, Päivi Heikkilä,[...]. J Clin Oncol 2005
53
12

Gene-expression profiles in hereditary breast cancer.
I Hedenfalk, D Duggan, Y Chen, M Radmacher, M Bittner, R Simon, P Meltzer, B Gusterson, M Esteller, O P Kallioniemi,[...]. N Engl J Med 2001
12

Molecular classification of familial non-BRCA1/BRCA2 breast cancer.
Ingrid Hedenfalk, Markus Ringner, Amir Ben-Dor, Zohar Yakhini, Yidong Chen, Gunilla Chebil, Robert Ach, Niklas Loman, Håkan Olsson, Paul Meltzer,[...]. Proc Natl Acad Sci U S A 2003
136
12

Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
Simon A Joosse, Kim I M Brandwijk, Peter Devilee, Jelle Wesseling, Frans B L Hogervorst, Senno Verhoef, Petra M Nederlof. Breast Cancer Res Treat 2012
38
12

Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.
Anita L Bane, Dushanthi Pinnaduwage, Sarah Colby, Michael Reedijk, Sean E Egan, Shelley B Bull, Frances P O'Malley, Irene L Andrulis. Breast Cancer Res Treat 2009
42
12

Gene expression profiling predicts clinical outcome of breast cancer.
Laura J van 't Veer, Hongyue Dai, Marc J van de Vijver, Yudong D He, Augustinus A M Hart, Mao Mao, Hans L Peterse, Karin van der Kooy, Matthew J Marton, Anke T Witteveen,[...]. Nature 2002
12

Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families.
Emiliano Honrado, Ana Osorio, Roger L Milne, María F Paz, Lorenzo Melchor, Alberto Cascón, Miguel Urioste, Alicia Cazorla, Orland Díez, Enrique Lerma,[...]. Mod Pathol 2007
42
12

Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay.
Nic Waddell, Sibylle Cocciardi, Julie Johnson, Sue Healey, Anna Marsh, Joan Riley, Leonard da Silva, Ana Cristina Vargas, Lynne Reid, Peter T Simpson,[...]. J Pathol 2010
59
12

Ki67 in breast cancer: prognostic and predictive potential.
Rinat Yerushalmi, Ryan Woods, Peter M Ravdin, Malcolm M Hayes, Karen A Gelmon. Lancet Oncol 2010
684
12

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas.
Christina Magkou, Lydia Nakopoulou, Christina Zoubouli, Kanelina Karali, Irene Theohari, Panagiotis Bakarakos, Ioanna Giannopoulou. Breast Cancer Res 2008
60
12

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
Antonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, Karen L Hagerty, D Craig Allred, Richard J Cote, Mitchell Dowsett, Patrick L Fitzgibbons, Wedad M Hanna, Amy Langer,[...]. J Clin Oncol 2007
12

Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour?
D Coradini, S Oriana, L Mariani, R Miceli, G Bresciani, E Marubini, G Di Fronzo. Eur J Cancer 1998
47
12

Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype.
Hoiseon Jeong, Young-joon Ryu, Jungsuk An, Youngseok Lee, Aeree Kim. Histopathology 2012
78
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.